Clinical Trials Directory

Trials / Completed

CompletedNCT04260516

The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
3 Years – 14 Years
Healthy volunteers
Not accepted

Summary

The effect of N-acetylcysteine as antioxidant and its effect on pretransfusion hemoglobin and iron overload in patients with thalassemia were compared to patients who didn't receive n-acetylcysteine after 3 months of study duration

Detailed description

N-acetylcysteine( NAC) is a widely used mucolytic drug and several studies had reported its efficacy as anti oxidant. Patients with thalassemia major are at great risk for oxidative stress due to excess of b-globin chains and iron overload. In this study the investigators compared the effect of NAC on oxidative status , pretransfusion hemoglobin levels and iron overload in thalassemia patients before and after treatment with NAC for 3 months and with that of patients who served as controls.

Conditions

Interventions

TypeNameDescription
DRUGN-acetyl cysteineMucolytic and antioxidant drug

Timeline

Start date
2019-06-03
Primary completion
2019-12-03
Completion
2019-12-30
First posted
2020-02-07
Last updated
2020-02-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04260516. Inclusion in this directory is not an endorsement.